30 Sept 2026, 09:18
Presentations—
CMBCAMBIUM BIO LIMITED
Announcement history available from 1 August 2025
Fromto
28 Sept 2026, 09:39
Meetings & Governance—
24 Sept 2026, 09:11
Securities Administration—
23 Sept 2026, 10:10
Securities Administration—
16 Sept 2026, 12:03
Capital RaisingMS
16 Sept 2026, 11:39
Securities Administration—
16 Sept 2026, 09:52
Substantial Holders—
16 Sept 2026, 09:51
Director Interests—
2 Sept 2026, 10:35
Securities Administration—
2 Sept 2026, 09:38
Securities Administration—
1 Sept 2026, 11:48
Securities Administration—
28 Aug 2026, 17:09
Company Administration—
28 Aug 2026, 17:08
Financial ResultsMS
27 Aug 2026, 11:35
Company Administration—
5 Aug 2026, 09:31
Company Administration—
30 July 2026, 08:51
Quarterly ReportsMS
24 July 2026, 09:37
Substantial Holders—
24 July 2026, 09:07
Securities Administration—
24 July 2026, 09:04
Securities Administration—
22 July 2026, 08:46
Securities Administration—
22 July 2026, 08:44
Capital RaisingMS
24 June 2026, 12:12
Substantial Holders—
24 June 2026, 10:28
Substantial Holders—
16 June 2026, 10:43
Substantial Holders—
28 Apr 2026, 09:10
Quarterly ReportsMS
23 Apr 2026, 13:01
Company UpdateMS
24 Mar 2026, 16:31
Director Interests—
17 Mar 2026, 09:38
Securities Administration—
17 Mar 2026, 09:21
Securities Administration—
16 Mar 2026, 13:23
Meetings & Governance—
20 Feb 2026, 09:39
Financial ResultsMS
11 Feb 2026, 10:52
Securities Administration—
11 Feb 2026, 10:52
Presentations—
23 Jan 2026, 09:14
Quarterly ReportsMS
20 Jan 2026, 08:19
Securities Administration—
20 Jan 2026, 08:19
Capital RaisingMS
27 Oct 2025, 15:50
Quarterly ReportsMS
27 Oct 2025, 15:20
Director Interests—
24 Oct 2025, 08:18
Director Interests—
24 Oct 2025, 08:18
Director Interests—
17 Oct 2025, 10:26
Securities Administration—
16 Oct 2025, 16:09
Securities Administration—
16 Oct 2025, 15:56
Securities Administration—
16 Oct 2025, 15:54
Securities Administration—
16 Oct 2025, 15:09
Meetings & Governance—
16 Oct 2025, 10:33
Presentations—
30 Sept 2025, 13:32
Company Update—
15 Sept 2025, 10:31
Securities Administration—
15 Sept 2025, 10:27
Meetings & Governance—
5 Sept 2025, 11:37
Company UpdateMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 09:18 | Corporate Presentation - September 2026 | Presentations | — | 03026 | |
| 28 Sept 2026, 09:39 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 24 Sept 2026, 09:11 | Notification of cessation of securities - CMB | Securities Administration | — | 06027 | |
| 23 Sept 2026, 10:10 | Notification regarding unquoted securities - CMB | Securities Administration | — | 06021 | |
| 16 Sept 2026, 12:03 | Cambium Bio Secures A$10.85 Million Funding Package | Capital Raising | MS | 06003, 06009 | |
| 16 Sept 2026, 11:39 | Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 16 Sept 2026, 09:52 | Notice of ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 16 Sept 2026, 09:51 | Change in Substantial Holding | Director Interests | — | 02009 | |
| 2 Sept 2026, 10:35 | Update - Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 2 Sept 2026, 09:38 | Notification regarding unquoted securities - CMB | Securities Administration | — | 06021 | |
| 1 Sept 2026, 11:48 | Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 28 Aug 2026, 17:09 | FY26 Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Aug 2026, 17:08 | FY26 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 Aug 2026, 11:35 | Change in Company Secretary and Communication Person | Company Administration | — | 12007, 12008 | |
| 5 Aug 2026, 09:31 | Updated Securities Trading Policy | Company Administration | — | 14013 | |
| 30 July 2026, 08:51 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 24 July 2026, 09:37 | Change in substantial holding - BW | Substantial Holders | — | 02002 | |
| 24 July 2026, 09:07 | Cleansing Notice | Securities Administration | — | 06018 | |
| 24 July 2026, 09:04 | Application for quotation of securities - CMB | Securities Administration | — | 06020 | |
| 22 July 2026, 08:46 | Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 22 July 2026, 08:44 | Cambium Bio Raises A$1.0 Million via Placement | Capital Raising | MS | 06003 | |
| 24 June 2026, 12:12 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 24 June 2026, 10:28 | Change in substantial holding - ZYBT | Substantial Holders | — | 02002 | |
| 16 June 2026, 10:43 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 28 Apr 2026, 09:10 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 23 Apr 2026, 13:01 | FDA Confirms Single Pivotal Trial Pathway for Elate Ocular | Company Update | MS | 11001 | |
| 24 Mar 2026, 16:31 | Change of Directors Interest Notice - ST | Director Interests | — | 02009 | |
| 17 Mar 2026, 09:38 | Cleansing Notice | Securities Administration | — | 06018 | |
| 17 Mar 2026, 09:21 | Application for quotation of securities - CMB | Securities Administration | — | 06020 | |
| 16 Mar 2026, 13:23 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 20 Feb 2026, 09:39 | Half Year Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 11 Feb 2026, 10:52 | Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 11 Feb 2026, 10:52 | Notice of General Meeting/Proxy Form | Presentations | — | 06010, 08004, 08007, 14014 | |
| 23 Jan 2026, 09:14 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 20 Jan 2026, 08:19 | Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 20 Jan 2026, 08:19 | Cambium Bio Secures A$2.4 Million Strategic Investment | Capital Raising | MS | 06003 | |
| 27 Oct 2025, 15:50 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19001, 19006 | |
| 27 Oct 2025, 15:20 | Corrective Appendix 3Y Terrence Walts | Director Interests | — | 02009 | |
| 24 Oct 2025, 08:18 | Change of Directors Interest Notice - TW | Director Interests | — | 02009 | |
| 24 Oct 2025, 08:18 | Change of Directors Interest Notice - EW | Director Interests | — | 02009 | |
| 17 Oct 2025, 10:26 | Amended Constitution | Securities Administration | — | 12012 | |
| 16 Oct 2025, 16:09 | Cleansing notice | Securities Administration | — | 06018 | |
| 16 Oct 2025, 15:56 | Notification regarding unquoted securities - CMB | Securities Administration | — | 06021 | |
| 16 Oct 2025, 15:54 | Application for quotation of securities - CMB | Securities Administration | — | 06020 | |
| 16 Oct 2025, 15:09 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 16 Oct 2025, 10:33 | Cambium AGM CEO address | Presentations | — | 03026, 15002 | |
| 30 Sept 2025, 13:32 | Cambium Bio Signs Manufacturing MOU with Locus Cell | Company Update | — | 11001 | |
| 15 Sept 2025, 10:31 | Proposed issue of securities - CMB | Securities Administration | — | 06013 | |
| 15 Sept 2025, 10:27 | Notice of Annual General Meeting and Proxy form | Meetings & Governance | — | 08001, 08004 | |
| 5 Sept 2025, 11:37 | Cambium Bio Signs Strategic MoU with Benta SAS | Company Update | MS | 11001 |
1–50 of 57
1 / 2